Sever's Disease in a Patient Receiving Growth Hormone with no Causative Relation

Kurnaz E., Savas-Erdeve S., AYCAN Z., Cetinkaya S.

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, cilt.12, sa.3, 2018 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.7860/jcdr/2018/30956.11305
  • Dergi Adı: JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: Calcaneal apophysitis, Heel pain, Somatropin treatment, CALCANEAL APOPHYSITIS, POPULATION, CHILDREN, THERAPY, PAIN
  • Ankara Üniversitesi Adresli: Hayır

Özet

Growth Hormone (GH) shows its main effect on bones and muscle tissues. There are reports of orthopaedic complications including carpal tunnel syndrome, Legg-Calve-Perthe's disease, scoliosis, and slipped capital femoral epiphysis with GH use in the literature, except for calcaneal apophysitis (Sever's disease). We hereby present the case of a 13-year-old male who was treated with GH for GH deficiency and developed Sever's disease in the first year of treatment.